ACAD
36.77
+1.08
+3.03%
AEMD
0.196
-0.01
-4.6341%
APRI
1.61
+0.05
+3.21%
ARNA
4.13
-0.08
-1.90%
ATEC
1.31
0.00
0.00%
CNAT
5.95
-0.11
-1.82%
CRXM
0.44
-0.04
-8.05%
CYTX
0.71
+0.00
+0.0423%
DXCM
66.32
+0.12
+0.18%
GNMK
9.38
-0.4
-4.09%
HALO
15.18
+0.06
+0.40%
ILMN
188.55
+1.51
+0.81%
INNV
0.152
+0.003
+2.013%
INO
8.09
-0.18
-2.18%
ISCO
0.055
0.00
0.00%
ISIS
60.37
+2.03
+3.48%
LGND
78.45
+0.78
+1.00%
LPTN
2.06
+0.01
+0.49%
MBVX
2.97
+0.03
+1.0170%
MEIP
2.02
-0.02
-0.98%
MNOV
4.11
+0.11
+2.75%
MRTX
28.4
+0.32
+1.14%
MSTX
0.54
-0.01
-1.28%
NBIX
36.66
+1.05
+2.95%
NUVA
46
-0.65
-1.39%
ONCS
0.306
+0.037
+13.755%
ONVO
4.75
-0.11
-2.26%
OREX
6.495
-0.115
-1.740%
OTIC
27.34
+0.17
+0.63%
QDEL
22.82
-0.04
-0.17%
RCPT
144.63
-1.46
-1.00%
RGLS
13
+0.24
+1.88%
RMD
64.83
+0.22
+0.34%
SCIE
0.021
-0.001
-5.9091%
SPHS
0.67
-0.03
-4.96%
SRNE
10.97
+0.56
+5.38%
TROV
9.75
+1.32
+15.66%
VICL
0.895
-0.013
-1.399%
VOLC
17.99
0.00
0.00%
ZGNX
1.39
-0.01
-0.71%
ACAD
36.77
+1.08
+3.03%
AEMD
0.196
-0.01
-4.6341%
APRI
1.61
+0.05
+3.21%
ARNA
4.13
-0.08
-1.90%
ATEC
1.31
0.00
0.00%
CNAT
5.95
-0.11
-1.82%
CRXM
0.44
-0.04
-8.05%
CYTX
0.71
+0.00
+0.0423%
DXCM
66.32
+0.12
+0.18%
GNMK
9.38
-0.4
-4.09%
HALO
15.18
+0.06
+0.40%
ILMN
188.55
+1.51
+0.81%
INNV
0.152
+0.003
+2.013%
INO
8.09
-0.18
-2.18%
ISCO
0.055
0.00
0.00%
ISIS
60.37
+2.03
+3.48%
LGND
78.45
+0.78
+1.00%
LPTN
2.06
+0.01
+0.49%
MBVX
2.97
+0.03
+1.0170%
MEIP
2.02
-0.02
-0.98%
MNOV
4.11
+0.11
+2.75%
MRTX
28.4
+0.32
+1.14%
MSTX
0.54
-0.01
-1.28%
NBIX
36.66
+1.05
+2.95%
NUVA
46
-0.65
-1.39%
ONCS
0.306
+0.037
+13.755%
ONVO
4.75
-0.11
-2.26%
OREX
6.495
-0.115
-1.740%
OTIC
27.34
+0.17
+0.63%
QDEL
22.82
-0.04
-0.17%
RCPT
144.63
-1.46
-1.00%
RGLS
13
+0.24
+1.88%
RMD
64.83
+0.22
+0.34%
SCIE
0.021
-0.001
-5.9091%
SPHS
0.67
-0.03
-4.96%
SRNE
10.97
+0.56
+5.38%
TROV
9.75
+1.32
+15.66%
VICL
0.895
-0.013
-1.399%
VOLC
17.99
0.00
0.00%
ZGNX
1.39
-0.01
-0.71%
Home » Archive by Category

Syndication

Engineer 1 – Process Development – Illumina, Inc. – San Diego, CA

May 4, 2015 – 5:00 pm

These individuals will provide technical leadership to new product introduction, production process development, improvement and sustaining efforts….
From Illumina, Inc. – 05 May 2015 18:02:00 GMT
– View all San Diego jobs

Halozyme Therapeutics, Inc. To Host First Quarter 2015 Financial Results Conference Call

May 4, 2015 – 5:00 pm

SAN DIEGO, May 4, 2015 /PRNewswire/ –Halozyme Therapeutics, Inc. (NASDAQ: HALO) will webcast its Quarterly Update Conference Call for the first quarter 2015 on Monday, May 11, 2015 at 4:30 p.m. ET/1:30 p.m. PT. Dr.

Cosmederm Bioscience Release: New Clinical Research Finds TriCalm Hydrogel’s Itch Relief Significantly Superior To Leading OTC Treatments

May 4, 2015 – 5:00 pm

SAN DIEGO, May 5, 2015 /PRNewswire/ –A study conducted to assess the antipruritic effect of over-the-counter (OTC) steroid-free topical hydrogel formulation, TriCalm, in reducing itch intensity and duration, has been published in Clinical,Cosmetic, an…

MabVax Therapeutics, Inc.’ Human Antibody Clinical Development Candidate HuMab 5B1 Successfully Clears Important Early Toxicology Testing

May 4, 2015 – 5:00 pm

SAN DIEGO, May 5, 2015 /PRNewswire/ –MabVax Therapeutics Holdings, Inc. (OTCQB: MBVX), a clinical stage oncology drug development company, announced today it has received the final report on toxicology testing of its HuMab 5B1 antibody, which was comp…

Orexigen To Host First Quarter 2015 Financial Results Conference Call

May 4, 2015 – 5:00 pm

SAN DIEGO, May 5, 2015 /PRNewswire/ –Orexigen Therapeutics, Inc. (Nasdaq: OREX) will announce financial results for the first quarter 2015 on Friday, May 8 before the market opens. The announcement will be followed by a live webcast and conference cal…

Tocagen Inc. Appoints To The Board Of Directors

May 4, 2015 – 5:00 pm

SAN DIEGO, May 5, 2015 /PRNewswire/ –Tocagen Inc., a clinical-stage immuno-oncology company, today announced that David R. Parkinson, M.D., a venture partner at New Enterprise Associates (NEA), has been appointed…

Ligand Pharmaceuticals Inc. Partner Viking Therapeutics Announces Closing of IPO

May 4, 2015 – 5:00 pm

SAN DIEGO–(BUSINESS WIRE)–Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) partner Viking Therapeutics, Inc. (NASDAQ: VKTX) announced that it had closed its initial public offering (the Viking IPO) of 3,000,000 shares of its commo…

Cytori Therapeutics, Inc. Prices Registered Direct Offering Providing For Up To $25 Million In Equity Financing

May 4, 2015 – 5:00 pm

SAN DIEGO–(BUSINESS WIRE)–Cytori Therapeutics, Inc. (NASDAQ: CYTX) today announced the pricing of a registered direct public offering of Units, with each Unit consisting of one share of our common stock and one warrant to purchase one sha…

Isis Pharma Reports Financial Results And Highlights For First Quarter 2015

May 4, 2015 – 5:00 pm

CARLSBAD, Calif., May 5, 2015 /PRNewswire/ — Isis Pharmaceuticals, Inc. (Nasdaq: ISIS) today reported pro forma operating income of $4.0 million for the three months ended March 31, 2015 compared to a pro forma net operating loss of

Isis Pharma Reports Financial Results And Highlights For First Quarter 2015

May 4, 2015 – 5:00 pm

CARLSBAD, Calif., May 5, 2015 /PRNewswire/ — Isis Pharmaceuticals, Inc. (Nasdaq: ISIS) today reported pro forma operating income of $4.0 million for the three months ended March 31, 2015 compared to a pro forma net operating loss of